Search for the latest oncology news by tumour type
A cancer immunotherapy drug currently approved by the U.S. Food and Drug Administration (FDA) to…
Early results from an Alliance for Clinical Trials in Oncology randomised clinical trial of adults…
A blood test, combined with a risk model based on an individual’s history, more accurately…
Scientists have revealed how cancer can resist PARP inhibitors. Their study found that some cancer…
A team of Vanderbilt researchers in the USA has revealed some of the mechanisms by…
The Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines was presented at the ESMO Asia…
Knock-on effects of early immune checkpoint inhibitor use stimulate consideration of alternative approaches for further…
The COSMIC-312 trial met its primary endpoint of progression-free survival, but interim overall survival results…
The Pan-Asian adaptation of the ESMO guidelines introduces some changes to the standard of care…
For nearly a decade, scientists have known that HIV integrates itself into genes in cells…